Motivational Interviewing to Increase Uptake of Drug Checking and Safe Drug Use Behaviors to Redu… (NCT06855836) | Clinical Trial Compass
Active — Not RecruitingNot Applicable
Motivational Interviewing to Increase Uptake of Drug Checking and Safe Drug Use Behaviors to Reduce Overdose
United States588 participantsStarted 2025-03-03
Plain-language summary
A hybrid type 1 study will be conducted to evaluate efficacy and preliminary implementation considerations for a novel intervention to promote uptake of drug checking services (DCS) and safer drug use behaviors among people who use drugs (PWUD) to reduce incidence of overdose (OD) and HIV and Hepatitis C virus (HCV) infections in San Diego County.
Approximately 50 syringe services programs (SSPs) in the US now offer advanced drug checking services using test strips (TS) and Fourier Transform Infrared Spectrometry (FTIR), allowing people to submit drug samples with non-nominal identifiers and obtain personalized results. While most existing FTIRs offer some counseling, no theory-based interventions to increase FTIR uptake and promote post-FTIR adoption of safer drug use behaviors have been rigorously evaluated.
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
✓. Provision of signed and dated informed consent form
✓. Stated willingness to comply with all study procedures and availability for the duration of the study
✓. Be aged ≥18 years at time of recruitment
✓. Must have used illicit opiates (e.g., heroin, fentanyl) and/or methamphetamine ≤1 week prior to recruitment date
✓. Live in San Diego County with no plans to permanently move over the next 30 months
✓. Have not previously used the FTIR drug checking service
✓. Enrolled into ongoing prospective cohort study La Frontera (the border) (existing or new participants)
Exclusion criteria
✕. Not being able to provide a signed and dated informed consent form
✕. Not willing to comply with all study procedures and availability for the duration of the study
✕
What they're measuring
1
Risk rates of fatal and non-fatal overdose over 30 months
Timeframe: Through study completion, an average of 30 months